Summary
Combretastatin A4, a novel anti-mitotic agent was effective against two P388 cell lines with acquired resistance to daunorubicin. In contrast, Combretastatin A1, a close structural analogue of A4, showed a high degree of cross-resistance. Combretastatin A1 was also more efficient at increasing intracellular daunorubicin concentrations in both resistant cell lines. Neither agent was capable of altering anthracycline accumulation in the parental (sensitive) cell line. We propose that the cross-resistance to Combretastatin A1 occurs, at least in part, as a result of the increased affinity of the drug-efflux process operative in these resistant cells for Combretastatin A1 vs Combretastatin A4. Hence, Combretastatin A4 may play a role in the treatment of tumours with acquired resistance to the anthracycline antibiotics.
References
Capranico G, Dasdia T, Zunino F (1986) Comparison of doxorubicin-induced DNA damage in doxorubicin-sensitive and -resistant P388 murine leukemia cells. Int J Cancer 37: 227
Cornwell MM, Pastan I, Gottesman MM (1987) Certain calcium channel blockers bind specifically to multidrug-resistant human KB carcinoma membrane vesicles and inhibit drug binding to P-glycoprotein. J Biol Chem 262: 2166
Kessel D, Wilberding C (1984) Interactions between calcium antagonists, calcium fluxes and anthracycline transport. Cancer Lett 25: 97
McGown AT, Fox BW (1983) Comparative studies of the uptake of daunorubicin in sensitive and resistant cell lines by flow cytometry and biochemical extraction procedures. Cancer Chemother Pharmacol 11: 113
McGown AT, Fox BW (1989) Structural and biochemical comparison of the anti-mitotic agents colchicine, combretastatin A4 and amphethinile. Anti-Cancer Drug Des 3: 249
Pettit GR, Singh SB, Niven ML, Hamel E, Schmidt JM (1987) Antineoplastic agents: 123. Isolation, structure and synthesis of Combretastatins A1 and B1, potent new inhibitors of microtubule assembly, derived from Combretum caffrum. J Nat Prod 50: 119
Pettit GR, Singh SB, Hamel E, Lin CM, Alberts DS, Garcia-Kendall D (1989) Isolation and structure of the strong cell growth and tubulin inhibitor combretastatin A4. Experentia 45: 209 - 211
Poppitt DG, McGown AT, Fox BW (1984) Collateral sensitivity of a methotrexate-resistant L1210 cell line to the vinca alkaloids. Cancer Chemother Pharmacol 13: 43
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McGown, A.T., Fox, B.W. Differential cytotoxicity of Combretastatins A1 and A4 in two daunorubicin-resistant P388 cell lines. Cancer Chemother Pharmacol 26, 79–81 (1990). https://doi.org/10.1007/BF02940301
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02940301